MariMed Commences Operations In Newly Expanded Area of Maryland Cultivation Facility
NORWOOD, Mass., July 22, 2024 (GLOBE NEWSWIRE) — MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced it recently commenced operations in the newly expanded area of its cultivation and processing facility in Hagerstown, Maryland. The expansion will double the facility’s flower capacity, enabling MariMed to meet the growing demand for its flower, concentrates, and edibles products in the state.
Related news for (MRMD)
- MariMed’s Products to Enter Pennsylvania Market Through a Management Services and Licensing Agreement with TILT Holdings
- MariMed Reports Fourth Quarter and Full Year 2024 Earnings
- MariMed Completes Acquisition of First State Compassion, Strengthening Market Position in Delaware
- MariMed Commences Wholesale Operations in Missouri
- MariMed Reports Second Quarter 2024 Earnings